Insider Trading › BLUE › Insiders
BLUE
BLUE·Insider activity
—
No end-of-day price on record
BLUE
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BLUES&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of BLUE were filed in the last 180 days. Newest filing Mar 5, 2025 (1 year ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by BLUE insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$0Sales · 180 days
1,071Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of BLUE common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
1,071 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Colvin Richard AChief Medical Officer | Sale | −584 | $3.92 | $2K | 7,610direct | Mar 3, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −500 | $3.92 | $2K | 7,878direct | Mar 3, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −921 | $3.92 | $4K | 18.3Kdirect | Mar 3, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −122 | $7.39 | $902 | 8,378direct | Feb 3, 2025 | Feb 5, 2025 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −64 | $7.39 | $473 | 8,194direct | Feb 3, 2025 | Feb 5, 2025 | Form 4 ↗ |
| Vittiglio JosephChief Business & Legal Officer | Sale | −238 | $7.39 | $2K | 4,501direct | Feb 3, 2025 | Feb 5, 2025 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −86 | $7.39 | $636 | 18.5Kdirect | Feb 3, 2025 | Feb 5, 2025 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −19 | $9.24 | $176 | 8,257direct | Jan 6, 2025 | Jan 8, 2025 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −140 | $9.24 | $1K | 18.6Kdirect | Jan 6, 2025 | Jan 8, 2025 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −971 | $0.42 | $408 | 374.2Kdirect | Dec 10, 2024 | Dec 12, 2024 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −2,824 | $0.42 | $1K | 165.5Kdirect | Dec 10, 2024 | Dec 12, 2024 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −1,006 | $0.53 | $533 | 170.0Kdirect | Sep 30, 2024 | Oct 2, 2024 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −34.8K | $0.53 | $18K | 375.2Kdirect | Sep 30, 2024 | Oct 2, 2024 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −3,834 | $0.97 | $4K | 121.0Kdirect | Jun 3, 2024 | Jun 4, 2024 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −6,095 | $1.53 | $9K | 280.0Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −4,573 | $1.53 | $7K | 124.8Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −6,770 | $1.53 | $10K | 118.4Kdirect | Mar 1, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −2,714 | $0.90 | $2K | 129.4Kdirect | Feb 5, 2024 | Feb 6, 2024 | Form 4 ↗ |
| Vittiglio JosephChief Business & Legal Officer | Sale | −5,217 | $0.90 | $5K | 44.8Kdirect | Feb 5, 2024 | Feb 6, 2024 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −1,879 | $0.90 | $2K | 286.1Kdirect | Feb 5, 2024 | Feb 6, 2024 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −3,162 | $1.43 | $5K | 288.0Kdirect | Jan 5, 2024 | Jan 9, 2024 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −597 | $1.42 | $848 | 125.1Kdirect | Jan 5, 2024 | Jan 9, 2024 | Form 4 ↗ |
| Krawtschuk ChristopherChief Financial Officer | Sale | −4,526 | $4.52 | $20K | 45.5Kdirect | Dec 6, 2023 | Dec 8, 2023 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −807 | $3.17 | $3K | 291.1Kdirect | Nov 3, 2023 | Nov 3, 2023 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −2,343 | $2.98 | $7K | 125.7Kdirect | Nov 2, 2023 | Nov 3, 2023 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −922 | $3.79 | $3K | 132.1Kdirect | Sep 5, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −16.9K | $3.54 | $60K | 291.9Kdirect | Aug 10, 2023 | Aug 10, 2023 | Form 4 ↗ |
| Klima Thomas JSee Remarks | Sale | −4,130 | $3.50 | $14K | 133.0Kdirect | Jun 2, 2023 | Jun 6, 2023 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −3,178 | $7.80 | $25K | 242.7Kdirect | Jan 11, 2023 | Jan 13, 2023 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −557 | $7.80 | $4K | 74.2Kdirect | Jan 11, 2023 | Jan 13, 2023 | Form 4 ↗ |
| Leschly NickDirector | Sale | −4,290 | $7.80 | $33K | 280.1Kdirect | Jan 11, 2023 | Jan 13, 2023 | Form 4 ↗ |
| Colvin Richard AChief Medical Officer | Sale | −218 | $6.41 | $1K | 74.8Kdirect | Nov 4, 2022 | Nov 8, 2022 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −1,263 | $6.41 | $8K | 245.9Kdirect | Nov 4, 2022 | Nov 8, 2022 | Form 4 ↗ |
| Leiderman ElisabethDirector | Sale | −1,004 | $6.46 | $6K | 11.5Kdirect | Oct 17, 2022 | Mar 9, 2023 | Form 4 ↗ |
| Cole JasonChief Strategy & Financial Off | Sale | −14.2K | $5.53 | $78K | 189.5Kdirect | Aug 19, 2022 | Aug 23, 2022 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −21.8K | $4.39 | $96K | 247.1Kdirect | Aug 4, 2022 | Aug 8, 2022 | Form 4 ↗ |
| Cole JasonChief Strategy & Financial Off | Sale | −7,448 | $4.39 | $33K | 203.7Kdirect | Aug 4, 2022 | Aug 8, 2022 | Form 4 ↗ |
| Eggimann Anne-VirginieChief Regulatory Officer | Sale | −1,358 | $4.95 | $7K | 42.3Kdirect | Jul 12, 2022 | Jul 14, 2022 | Form 4 ↗ |
| Klima Thomas JChief Commercial Officer | Sale | −3,753 | $3.07 | $12K | 71.4Kdirect | Jun 3, 2022 | Jun 7, 2022 | Form 4 ↗ |
| Whitten JessicaChief Accounting Officer | Sale | −279 | $9.64 | $3K | 49.4Kdirect | Jan 11, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −3,387 | $9.64 | $33K | 186.2Kdirect | Jan 11, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Leschly NickDirector | Sale | −5,068 | $9.64 | $49K | 281.3Kdirect | Jan 11, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −4,683 | $9.64 | $45K | 246.7Kdirect | Jan 11, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Whitten JessicaChief Accounting Officer | Sale | −130 | $9.40 | $1K | 49.7Kdirect | Jan 10, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −1,584 | $9.40 | $15K | 189.6Kdirect | Jan 10, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Leschly NickDirector | Sale | −2,369 | $9.40 | $22K | 286.4Kdirect | Jan 10, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −2,190 | $9.40 | $21K | 251.4Kdirect | Jan 10, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −852 | $9.24 | $8K | 253.6Kdirect | Jan 10, 2022 | Jan 12, 2022 | Form 4 ↗ |
| Whitten JessicaChief Accounting Officer | Sale | −2,984 | $10.44 | $31K | 49.8Kdirect | Jan 5, 2022 | Jan 7, 2022 | Form 4 ↗ |
| Obenshain AndrewPresident and CEO · Director | Sale | −832 | $10.18 | $8K | 254.4Kdirect | Dec 7, 2021 | Dec 9, 2021 | Form 4 ↗ |
| Obenshain AndrewPresident of SGD | Sale | −511 | $30.75 | $16K | 39.6Kdirect | Jun 4, 2021 | Jun 8, 2021 | Form 4 ↗ |
| Obenshain AndrewPresident of SGD | Sale | −29 | $30.15 | $874 | 40.1Kdirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −39 | $30.15 | $1K | 46.8Kdirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −444 | $30.15 | $13K | 306.7Kdirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −38 | $30.15 | $1K | 47.9Kdirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Obenshain AndrewPresident of SGD | Sale | −29 | $30.21 | $876 | 40.1Kdirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −444 | $30.21 | $13K | 307.1Kdirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −39 | $30.21 | $1K | 46.9Kdirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −42 | $30.21 | $1K | 47.8Kdirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −37 | $30.21 | $1K | 48.0Kdirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −444 | $29.58 | $13K | 104.2Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| Obenshain AndrewPresident of SGD | Sale | −34 | $29.58 | $1K | 40.2Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −42 | $29.58 | $1K | 47.8Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −38 | $29.58 | $1K | 48.0Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −39 | $29.58 | $1K | 46.9Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| Baird William D IIIChief Financial Officer | Sale | −693 | $28.16 | $20K | 35.5Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Burnett KatyPrincipal Accounting Officer | Sale | −518 | $28.16 | $15K | 4,097direct | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Obenshain AndrewPresident of SGD | Sale | −749 | $28.16 | $21K | 40.2Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −665 | $28.16 | $19K | 48.0Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −664 | $28.16 | $19K | 46.9Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −698 | $28.16 | $20K | 47.9Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Baird William D IIIChief Financial Officer | Sale | −1,216 | $45.52 | $55K | 21.6Kdirect | Feb 12, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Obenshain AndrewPresident of SGD | Sale | −34 | $45.93 | $2K | 23.9Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −63 | $45.93 | $3K | 36.3Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −594 | $45.93 | $27K | 86.7Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −38 | $45.93 | $2K | 32.8Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −59 | $45.93 | $3K | 32.9Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −4,222 | $45.46 | $192K | 87.3Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −5,873 | $44.76 | $263K | 91.5Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Baird William D IIIChief Financial Officer | Sale | −397 | $45.46 | $18K | 22.8Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Baird William D IIIChief Financial Officer | Sale | −552 | $44.76 | $25K | 23.2Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −759 | $45.46 | $35K | 25.1Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −1,055 | $44.76 | $47K | 25.9Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,324 | $45.46 | $60K | 36.4Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,843 | $44.76 | $82K | 37.7Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −986 | $45.46 | $45K | 32.8Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −1,372 | $44.76 | $61K | 33.8Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −538 | $45.46 | $24K | 20.6Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −749 | $44.76 | $34K | 21.1Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,152 | $45.46 | $52K | 33.0Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,602 | $44.76 | $72K | 34.2Kdirect | Jan 6, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −333 | $44.95 | $15K | 97.4Kdirect | Jan 5, 2021 | Jan 8, 2021 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −40 | $44.95 | $2K | 26.9Kdirect | Jan 5, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −48 | $44.95 | $2K | 39.5Kdirect | Jan 5, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −43 | $44.95 | $2K | 35.2Kdirect | Jan 5, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −42 | $44.95 | $2K | 21.9Kdirect | Jan 5, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −45 | $44.95 | $2K | 35.8Kdirect | Jan 5, 2021 | Jan 8, 2021 | Form 4 ↗ |
| Burnett KatyPrincipal Accounting Officer | Sale | −272 | $47.00 | $13K | 1,188direct | Dec 7, 2020 | Feb 10, 2021 | Form 4 ↗ |
| Burnett KatyPrincipal Accounting Officer | Sale | −123 | $46.09 | $6K | 1,460direct | Dec 3, 2020 | Dec 4, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −1 | $46.50 | $47 | 27.0Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −35 | $46.19 | $2K | 27.0Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −1 | $46.50 | $47 | 21.9Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −37 | $46.19 | $2K | 21.9Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −1 | $46.50 | $47 | 35.2Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −37 | $46.19 | $2K | 35.2Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −2 | $46.50 | $93 | 35.8Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −57 | $46.19 | $3K | 35.8Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2 | $46.50 | $93 | 39.6Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −62 | $46.19 | $3K | 39.6Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −14 | $46.50 | $651 | 97.7Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −430 | $46.19 | $20K | 97.7Kdirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −4 | $54.43 | $218 | 27.0Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −7 | $53.83 | $377 | 27.0Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −24 | $52.51 | $1K | 27.0Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −4 | $54.43 | $218 | 22.0Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −7 | $53.83 | $377 | 22.0Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneCOO, Oncology | Sale | −26 | $52.51 | $1K | 22.0Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −4 | $54.43 | $218 | 35.3Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −7 | $53.83 | $377 | 35.3Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −26 | $52.51 | $1K | 35.3Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −6 | $54.43 | $327 | 35.9Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −10 | $53.83 | $538 | 35.9Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −43 | $52.51 | $2K | 35.9Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −6 | $54.43 | $327 | 39.6Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −12 | $53.83 | $646 | 39.6Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −45 | $52.51 | $2K | 39.7Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −45 | $54.43 | $2K | 98.1Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −80 | $53.83 | $4K | 98.2Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −319 | $52.51 | $17K | 98.3Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −64 | $52.77 | $3K | 39.7Kdirect | Oct 2, 2020 | Oct 6, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −38 | $52.77 | $2K | 35.3Kdirect | Oct 2, 2020 | Oct 6, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −38 | $52.77 | $2K | 22.0Kdirect | Oct 2, 2020 | Oct 6, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −36 | $52.77 | $2K | 27.0Kdirect | Oct 2, 2020 | Oct 6, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −450 | $52.77 | $24K | 98.6Kdirect | Oct 2, 2020 | Oct 6, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −60 | $52.77 | $3K | 35.9Kdirect | Oct 2, 2020 | Oct 6, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −35 | $58.60 | $2K | 27.1Kdirect | Sep 3, 2020 | Sep 8, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −36 | $58.60 | $2K | 22.1Kdirect | Sep 3, 2020 | Sep 8, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −36 | $58.60 | $2K | 35.3Kdirect | Sep 3, 2020 | Sep 8, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −58 | $58.60 | $3K | 36.0Kdirect | Sep 3, 2020 | Sep 8, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −41 | $58.60 | $2K | 39.8Kdirect | Sep 3, 2020 | Sep 8, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −431 | $58.60 | $25K | 99.0Kdirect | Sep 3, 2020 | Sep 8, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −225 | $58.95 | $13K | 22.1Kdirect | Aug 25, 2020 | Aug 27, 2020 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −82 | $61.00 | $5K | 9,512direct | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −11 | $61.98 | $682 | 39.8Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −31 | $60.32 | $2K | 39.8Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −112 | $60.98 | $7K | 99.5Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −332 | $60.32 | $20K | 99.6Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −9 | $60.98 | $549 | 35.4Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −28 | $60.32 | $2K | 35.4Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −9 | $60.98 | $549 | 22.3Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −28 | $60.32 | $2K | 22.3Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −9 | $60.98 | $549 | 27.1Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −26 | $60.32 | $2K | 27.1Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −15 | $60.98 | $915 | 36.0Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −44 | $60.32 | $3K | 36.1Kdirect | Aug 3, 2020 | Aug 5, 2020 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −596 | $66.38 | $40K | 9,594direct | Jul 20, 2020 | Jul 22, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −42 | $61.57 | $3K | 39.9Kdirect | Jul 2, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −443 | $61.57 | $27K | 99.9Kdirect | Jul 2, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −38 | $61.57 | $2K | 35.4Kdirect | Jul 2, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −38 | $61.57 | $2K | 22.3Kdirect | Jul 2, 2020 | Jul 7, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −36 | $61.57 | $2K | 27.1Kdirect | Jul 2, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −59 | $61.57 | $4K | 36.1Kdirect | Jul 2, 2020 | Jul 7, 2020 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −62 | $65.56 | $4K | 10.2Kdirect | Jun 4, 2020 | Jun 8, 2020 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −92 | $65.01 | $6K | 10.3Kdirect | Jun 4, 2020 | Jun 8, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −69 | $65.56 | $5K | 22.4Kdirect | Jun 4, 2020 | Jun 8, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −101 | $65.01 | $7K | 22.5Kdirect | Jun 4, 2020 | Jun 8, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −28 | $64.24 | $2K | 22.6Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −9 | $63.36 | $570 | 22.6Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −29 | $64.24 | $2K | 35.4Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −9 | $63.36 | $570 | 35.5Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −32 | $64.24 | $2K | 39.9Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −10 | $63.36 | $634 | 39.9Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −341 | $64.24 | $22K | 100.3Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −103 | $63.36 | $7K | 100.7Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −27 | $64.24 | $2K | 27.2Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −8 | $63.36 | $507 | 27.2Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −45 | $64.24 | $3K | 36.2Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −14 | $63.36 | $887 | 36.2Kdirect | Jun 2, 2020 | Jun 4, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −15 | $51.57 | $774 | 22.6Kdirect | May 4, 2020 | May 5, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −45 | $50.81 | $2K | 22.6Kdirect | May 4, 2020 | May 5, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −172 | $49.88 | $9K | 22.7Kdirect | May 4, 2020 | May 5, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −583 | $43.73 | $25K | 21.4Kdirect | Apr 6, 2020 | Apr 8, 2020 | Form 4 ↗ |
| Baird William D IIIChief Financial Officer | Sale | −1,254 | $90.60 | $114K | 13.7Kdirect | Feb 13, 2020 | Feb 18, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −600 | $94.03 | $56K | 24.7Kdirect | Jan 10, 2020 | Jan 14, 2020 | Form 4 ↗ |
| Smith-Farrell JoanneChief Business Officer | Sale | −408 | $89.97 | $37K | 12.0Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −223 | $89.97 | $20K | 6,308direct | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −1,049 | $89.97 | $94K | 18.1Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −1,957 | $89.97 | $176K | 25.0Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −3,297 | $89.97 | $297K | 28.3Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −4,134 | $89.97 | $372K | 24.7Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −10.2K | $89.97 | $914K | 56.7Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −250 | $86.66 | $22K | 28.8Kdirect | Jan 6, 2020 | Jan 8, 2020 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −517 | $84.96 | $44K | 19.2Kdirect | Jan 3, 2020 | Jan 7, 2020 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −397 | $92.59 | $37K | 6,449direct | Dec 19, 2019 | Dec 23, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,800 | $94.31 | $170K | 29.1Kdirect | Dec 17, 2019 | Dec 19, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −250 | $80.57 | $20K | 29.1Kdirect | Dec 5, 2019 | Dec 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −250 | $81.95 | $20K | 29.3Kdirect | Nov 5, 2019 | Nov 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −250 | $89.07 | $22K | 29.6Kdirect | Oct 7, 2019 | Oct 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,060 | $100.16 | $206K | 31.6Kdirect | Sep 10, 2019 | Sep 11, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −3,000 | $100.11 | $300K | 31.6Kdirect | Sep 9, 2019 | Sep 11, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −850 | $101.20 | $86K | 29.8Kdirect | Sep 5, 2019 | Sep 9, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −500 | $124.00 | $62K | 40.9Kdirect | Aug 20, 2019 | Aug 21, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −950 | $124.03 | $118K | 30.1Kdirect | Aug 8, 2019 | Aug 12, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −400 | $118.44 | $47K | 31.6Kdirect | Aug 6, 2019 | Aug 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −900 | $117.77 | $106K | 32.0Kdirect | Aug 6, 2019 | Aug 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −800 | $116.11 | $93K | 32.9Kdirect | Aug 6, 2019 | Aug 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,960 | $115.25 | $341K | 33.7Kdirect | Aug 6, 2019 | Aug 8, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −100 | $118.01 | $12K | 30.3Kdirect | Aug 5, 2019 | Aug 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −750 | $116.79 | $88K | 30.4Kdirect | Aug 5, 2019 | Aug 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −100 | $131.94 | $13K | 30.6Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −300 | $130.69 | $39K | 30.7Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −311 | $129.70 | $40K | 31.0Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,089 | $128.27 | $140K | 31.3Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −700 | $131.77 | $92K | 31.6Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −3,300 | $130.05 | $429K | 32.3Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −832 | $129.32 | $108K | 35.6Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,828 | $128.28 | $363K | 36.4Kdirect | Jul 5, 2019 | Jul 9, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −100 | $126.12 | $13K | 40.9Kdirect | Jun 18, 2019 | Jun 20, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −200 | $126.96 | $25K | 40.9Kdirect | Jun 10, 2019 | Jun 12, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −1,200 | $125.19 | $150K | 41.1Kdirect | Jun 10, 2019 | Jun 12, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,500 | $124.23 | $186K | 31.6Kdirect | Jun 6, 2019 | Jun 10, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,344 | $122.43 | $165K | 33.1Kdirect | Jun 6, 2019 | Jun 10, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,216 | $121.68 | $270K | 34.5Kdirect | Jun 6, 2019 | Jun 10, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −9 | $131.05 | $1K | 6,846direct | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −8 | $129.51 | $1K | 6,855direct | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −17 | $127.25 | $2K | 6,863direct | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −27 | $126.11 | $3K | 6,880direct | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −200 | $131.05 | $26K | 31.1Kdirect | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −400 | $130.09 | $52K | 31.3Kdirect | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −201 | $128.50 | $26K | 31.7Kdirect | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −999 | $127.54 | $127K | 31.9Kdirect | Jun 5, 2019 | Jun 7, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −200 | $133.08 | $27K | 40.9Kdirect | May 10, 2019 | May 14, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −1,100 | $132.38 | $146K | 41.1Kdirect | May 10, 2019 | May 14, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −200 | $131.11 | $26K | 42.2Kdirect | May 10, 2019 | May 14, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −600 | $138.93 | $83K | 31.6Kdirect | May 6, 2019 | May 8, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,200 | $138.19 | $166K | 32.2Kdirect | May 6, 2019 | May 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,060 | $140.02 | $148K | 31.6Kdirect | May 6, 2019 | May 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,600 | $139.24 | $362K | 32.7Kdirect | May 6, 2019 | May 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,700 | $138.25 | $373K | 35.3Kdirect | May 6, 2019 | May 8, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −400 | $157.23 | $63K | 40.9Kdirect | Apr 10, 2019 | Apr 12, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −1,100 | $156.44 | $172K | 41.3Kdirect | Apr 10, 2019 | Apr 12, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −700 | $158.92 | $111K | 32.1Kdirect | Apr 5, 2019 | Apr 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −300 | $157.91 | $47K | 32.8Kdirect | Apr 5, 2019 | Apr 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −800 | $156.33 | $125K | 33.1Kdirect | Apr 5, 2019 | Apr 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,033 | $161.14 | $166K | 31.6Kdirect | Apr 4, 2019 | Apr 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,704 | $160.22 | $433K | 32.6Kdirect | Apr 4, 2019 | Apr 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,623 | $159.47 | $418K | 35.4Kdirect | Apr 4, 2019 | Apr 8, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,401 | $146.95 | $206K | 31.6Kdirect | Mar 13, 2019 | Mar 15, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,700 | $145.96 | $248K | 33.0Kdirect | Mar 13, 2019 | Mar 15, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Strategy Officer | Sale | −1,500 | $139.80 | $210K | 40.9Kdirect | Mar 11, 2019 | Mar 13, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −600 | $149.14 | $89K | 32.6Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −300 | $148.58 | $45K | 33.2Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −300 | $147.38 | $44K | 33.5Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −600 | $146.02 | $88K | 33.8Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −400 | $157.70 | $63K | 31.6Kdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −338 | $157.00 | $53K | 32.0Kdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,225 | $155.85 | $347K | 32.4Kdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,947 | $155.07 | $302K | 34.6Kdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −51 | $151.71 | $8K | 6,695direct | Feb 28, 2019 | Mar 4, 2019 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −525 | $151.41 | $79K | 26.4Kdirect | Feb 25, 2019 | Feb 27, 2019 | Form 4 ↗ |
| Cole JasonChief Operating and | Sale | −5,723 | $150.13 | $859K | 27.0Kdirect | Feb 25, 2019 | Feb 27, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −208 | $150.00 | $31K | 6,746direct | Feb 25, 2019 | Feb 27, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Financial and | Sale | −500 | $131.87 | $66K | 40.9Kdirect | Feb 8, 2019 | Feb 12, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Financial and | Sale | −1,000 | $130.99 | $131K | 41.4Kdirect | Feb 8, 2019 | Feb 12, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −700 | $139.45 | $98K | 33.1Kdirect | Feb 5, 2019 | Feb 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −500 | $137.72 | $69K | 33.8Kdirect | Feb 5, 2019 | Feb 7, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −600 | $136.51 | $82K | 34.3Kdirect | Feb 5, 2019 | Feb 7, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,200 | $135.10 | $162K | 31.6Kdirect | Feb 4, 2019 | Feb 5, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −3,110 | $134.22 | $417K | 32.8Kdirect | Feb 4, 2019 | Feb 5, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −600 | $133.13 | $80K | 35.9Kdirect | Feb 4, 2019 | Feb 5, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −209 | $125.96 | $26K | 4,403direct | Jan 28, 2019 | Jan 30, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −2,035 | $130.05 | $265K | 22.2Kdirect | Jan 18, 2019 | Jan 23, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Financial | Sale | −3,000 | $125.14 | $375K | 32.5Kdirect | Jan 16, 2019 | Jan 18, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,900 | $124.25 | $236K | 26.8Kdirect | Jan 16, 2019 | Jan 18, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Financial | Sale | −1,033 | $114.31 | $118K | 32.5Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Walsh Jeffrey T.Chief Financial | Sale | −1,979 | $113.29 | $224K | 33.5Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −2,529 | $114.31 | $289K | 193.2Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Leschly NickPresident and CEO · Director | Sale | −4,845 | $113.29 | $549K | 195.7Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,037 | $114.31 | $119K | 27.3Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −1,992 | $113.29 | $226K | 28.4Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −437 | $107.41 | $47K | 30.4Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −400 | $109.48 | $44K | 30.8Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Gregory Philip DChief Scientific Officer | Sale | −13 | $109.70 | $1K | 31.2Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −219 | $114.30 | $25K | 14.5Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −424 | $113.29 | $48K | 14.8Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −916 | $114.31 | $105K | 22.2Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,748 | $113.29 | $198K | 23.2Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Cole JasonChief Legal Officer | Sale | −488 | $114.31 | $56K | 20.2Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Cole JasonChief Legal Officer | Sale | −928 | $113.29 | $105K | 20.7Kdirect | Jan 7, 2019 | Jan 9, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale Amended | −128 | $100.32 | $13K | 15.2Kdirect | Jan 3, 2019 | Jan 9, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale Amended | −228 | $99.27 | $23K | 15.3Kdirect | Jan 3, 2019 | Jan 9, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale Amended | −120 | $98.32 | $12K | 15.5Kdirect | Jan 3, 2019 | Jan 9, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −115 | $100.32 | $12K | 15.2Kdirect | Jan 3, 2019 | Jan 7, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −205 | $99.27 | $20K | 15.4Kdirect | Jan 3, 2019 | Jan 7, 2019 | Form 4 ↗ |
| FINGER ALISON CECILYChief Commercial Officer | Sale | −108 | $98.31 | $11K | 15.6Kdirect | Jan 3, 2019 | Jan 7, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −100 | $100.32 | $10K | 24.9Kdirect | Jan 3, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −4,700 | $100.09 | $470K | 24.9Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,200 | $97.05 | $116K | 24.9Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Davidson DavidChief Medical Officer | Sale | −1,600 | $96.35 | $154K | 26.1Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| WENTWORTH KORY JAMESPrincipal Accounting Officer | Sale | −388 | $103.05 | $40K | 4,612direct | Dec 19, 2018 | Dec 21, 2018 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →